RU
Oncology
Aprepitant PSK
Registration certificate:
LP-№(001754)-(RG-RU)
INN:
Aprepitant
Release form:
Capsules
Therapeutic Area:
Oncology
Pharmacotherapeutic Group:
Antiemetics, other antiemetics
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

Aprepitant PSK capsules are used in adults over the age of 18 in combination with other antiemetic agents to prevent acute and delayed nausea and vomiting caused by chemotherapy (use of antineoplastic agents).

Quality control
at all stages of production